Familial mediterranean fever differential diagnosis
Familial Mediterranean Fever Microchapters |
Differentiating Familial Mediterranean Fever from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Familial mediterranean fever differential diagnosis On the Web |
American Roentgen Ray Society Images of Familial mediterranean fever differential diagnosis |
Familial mediterranean fever differential diagnosis in the news |
Blogs on Familial mediterranean fever differential diagnosis |
Directions to Hospitals Treating Familial mediterranean fever |
Risk calculators and risk factors for Familial mediterranean fever differential diagnosis |
Differential diagnosis
Familial mediterranean fever (FMF) should be differentiated from other conditions presenting with fever, fatigue, weight loss, arthralgia, myalgia, rash and soft tissue swelling. The differentials include the following:[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25]
Category of Disease | Diseases | Signs and symptoms | Laboratory findings | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inheritance pattern | Fever duration | Frequency of attacks | Abdominal pain | Arthralgia/Arthritis | Chest pain | Skin rash | Myalgia/Body pain | Diarrhea/Vomiting | Neurologic manifestations | Conjunctivitis | Aphthous stomatitis | Lymphadenopathy | Splenomegaly | Complete blood count (CBC) | C- reactive protein (CRP) | |||||
Erythrocyte sedimentation rate (ESR) | Other findings | Genetic analysis | ||||||||||||||||||
Autoinflammatory diseases |
Familial mediterranean fever[26][27] |
|
|
+ | + | + |
|
+ | + | -/+ | -/+ | -/+ | + | ↑ | ↑ |
|
||||
Hyper IgD with recurrent fever[27][28][29] |
|
|
+ | + | + |
|
+ | + | - | +/- | +/- | +/- | ↑ | ↑ |
|
|||||
TNF receptor-associated periodic syndrome[30][31] |
|
|
+ | + | - | - | - | + | - | +/- | + | ↑ | ↑ | |||||||
Muckle-Wells Syndrome[32][33] |
|
|
+ | + | - | + | + | + | + | - | - | ↑ | ↑ |
|
||||||
Familial cold urticaria[27][34] |
|
|
- | + | - | - | - |
|
+ | +/- | - | - | ↑ | ↑ |
|
|||||
Neonatal onset multisystem inflammatory disease[27][35][36] |
|
|
+ | + | + | + | + | +/- | + | ↑ | ↑ |
|
||||||||
PSTPIP1-associated Arthritis, pyoderma gangrenosum and acne (PAPA)[37][38] |
|
|
+/- |
|
+/- | +/- | +/- | - | - | - | - | - | ↑ | ↑ |
|
|||||
Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA)[39][40][41] |
|
|
|
+ | + | - | - | + | + | - | - | + |
|
- | ↑ | ↑ |
|
| ||
Blau syndrome[42][43] |
|
|
+/- | + | +/- |
|
+ | +/- |
|
- | + | +/- | + | ↑ | ↑ |
|
Category of Disease | Diseases | Signs and symptoms | Laboratory findings | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Fatigue | Arthralgia | Myalgia | Soft tissue swelling/serositis | Skin rash | Weight loss | Dyspnea | Sore throat | Lymphadenopathy | Complete blood count (CBC) | Liver function tests (LFTs) |
Inflammatory markers |
Autoantibodies |
Diagnostic tests | ||||||||
Erythrocyte sedimentation rate (ESR) | C- reactive protein (CRP) | Anti-nuclear antibodies (ANA) | Rheumatoid factor (RF) | Anti- glomerular basement membrane (anti-GBM) | Anti-dsDNA | Anti-Jo1/ Anti Mi2 | ANCA | |||||||||||||||
Infections |
HIV | + | + | + | + | +/- | - | + | +/- | + /- | + | ↑ | ↑ | - | - | - | - | - | - | |||
Herpesviridae | + | + | + | + | + |
|
- | - | +/- | + | - | ↑ | ↑ | - | - | - | - | - | - | |||
Measles | + | + | + | + | - |
|
- | - | + | + | - | ↑ | ↑ | - | - | - | - | - | - | |||
Viral hepatitis | + | + | - | +/- | - | - | +/- | - | - | +/- | ↑ | ↑ | - | - | - | - | - | - | ||||
Parvovirus B19 | + | + | + | +/- | - |
|
- | - | - | + |
|
↑ | ↑ | - | - | - | - | - | - | |||
Infective endocarditis | + | + | + | +/- | - | +/- | + | - | + | - | ↑ | ↑ | - | - | - | - | - | - | Blood cultures, ultrasonography | |||
Borreliosis, Brucellosis, Yersiniosis | + | + | + | + | - |
|
- | - | - | + | ↑ | ↑ | - | - | - | - | - | - | Serology, PCR | |||
Syphilis and Jarisch-Herxheimer reaction | + | + | + | + | - |
|
- | - | + | + | ↑ | ↑ | - | - | - | - | - | - | Serology, PCR | |||
Toxoplasmosis | + | + | - | + | - |
|
- | - | + | + |
|
- | - | - | - | - | - | Serology, PCR | ||||
Neoplasia |
Malignant lymphoma | + | + | - | +/- | +/- | + | + | - | + |
|
↑ | ↑ | - | - | - | - | - | - | CT, PET/CT, Bone marrow examination, lymph node biopsy | ||
Multicentric Castleman disease | + | + | - | - | + | - | + | + | - | + | - | ↑ | ↑ | - | - | - | - | - | - | Lymph node biopsy | ||
Angioimmunoblastic T cell lymphoma | + | + | - | - | - |
|
+ | - | - | + | ↑ | ↑ | - | - | - | - | - | - | Lymph node biopsy | |||
Drug hypersensitivity |
Drug reaction with eosinophilia and systemic symptoms | + | + | + | + | +/- |
|
- | + | - | - | - | ↑ | ↑ | - | - | - | - | - | - | Eosinophil count, skin biopsy | |
Autoimmune conditions | Systemic lupus erythematosus | + | + | + | +/- | + |
|
+ | + | - | +/- | ↑ | ↑ | + | + | - | + | - | - | Antinuclear autoantibodies | ||
Inflammatory myositis | + | + | - | + (weakness > pain) | - | - | - | - | +/- | - | ↑ | ↑ | +/- | +/- | - | - | + | - | Idem, muscle biopsy | |||
Rheumatoid arthritis | + | + | + | - | + | - | + | - | + | - | ↑ | ↑ | +/- | +/- | - | - | - | - | Anti-citrullinated peptids autoantibodies, rheumatoid factor | |||
Systemic vasculitides | + | + | + | - | + |
|
- | +/- | - | +/- | - | ↑ | ↑ | - | - | +/- | - | - | + | ANCA, tissue biopsy, arteriography | ||
Familial Mediterranean fever | + | + | + | + | + |
|
+ | + (due to pain) | - | +/- |
|
- | ↑ | ↑ | - | - | - | - | - | - | Familial history, MEFV gene analysis | |
Mevalonate kinase deficiency | + | + | + | + | - |
|
+ | - | + | + |
|
- | ↑ | ↑ | - | - | - | - | - | - | Urinary mevalonic acid, mevalonate kinase analysis | |
Reactive arthritis | + | + | + | - | - |
|
- | + (Aortic insufficiency) | - | + | - | ↑ | ↑ | - | - | - | - | - | - | HLA B27, magnetic resonance imaging | ||
Miscellaneous |
Sarcoidosis | + | + | + | - | + |
|
+ | + | - | + | ↑ | ↑ | - | - | - | - | - | - |
|
Less common differentials
FMF must be differentiated from other causes of secondary peritonitis
Disease | Prominent clinical findings | Lab tests | Tratment | |
---|---|---|---|---|
Primary peritonitis | Spontaneous bacterial peritonitis |
|
|
|
Tuberculous peritonitis |
|
|
| |
Continuous Ambulatory Peritoneal Dialysis (CAPD peritonitis) |
|
|
| |
Secondary peritonitis | Acute bacterial secondary peritonitis |
|
| |
Biliary peritonitis |
|
|||
Tertiary peritonitis |
|
|
| |
Familial Mediterranean fever (periodic peritonitis, familial paroxysmal polyserositis) |
|
| ||
Granulomatous peritonitis |
|
|
| |
Sclerosing encapsulating peritonitis |
|
|||
Intraperitoneal abscesses |
|
|
| |
Peritoneal mesothelioma |
|
|
| |
peritoneal carcinomatosis |
|
Classification of acute abdomen based on etiology | Presentation | Symptoms | Signs | Diagnosis | Comments | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Abdominal Pain | Jaundice | Guarding | Rebound Tenderness | Bowel sounds | Lab Findings | Imaging | ||||
Common causes of Peritonitis | Primary Peritonitis | Spontaneous bacterial peritonitis | + | Diffuse | - | - | - | Hypoactive |
|
Ultrasound for evaluation of liver cirrhosis | - |
Secondary Peritonitis | Perforated gastric and duodenal ulcer | + | Diffuse | - | + | + | N |
|
Air under diaphragm in upright CXR | Upper GI endoscopy for diagnosis | |
Acute cholangitis | + | RUQ | + | - | - | N | Abnormal LFT | Ultrasound shows biliary dilatation | Biliary drainage (ERCP) + IV antibiotics | ||
Acute cholecystitis | + | RUQ | + | - | - | Hypoactive | Ultrasound shows gallstone and evidence of inflammation | Murphy’s sign | |||
Acute pancreatitis | + | Epigastric | +/- | - | - | N | Increased amylase / lipase | Ultrasound shows evidence of inflammation | Pain radiation to back | ||
Acute appendicitis | + | RLQ | - | + | + | Hypoactive | Leukocytosis | Ultrasound shows evidence of inflammation | Nausea & vomiting, decreased appetite | ||
Acute diverticulitis | + | LLQ | +/- | + | - | Hypoactive | Leukocytosis | CT scan and ultrasound shows evidence of inflammation | |||
Acute salpingitis | + | LLQ/ RLQ | - | +/- | +/- | N | Leukocytosis | Pelvic ultrasound | Vaginal discharge | ||
Hollow Viscous Obstruction | Small intestine obstruction | - | Diffuse | - | + | +/- | Hyperactive then absent | Leukocytosis | Abdominal X ray | Nausea & vomiting associated with constipation, abdominal distention | |
Volvulus | - | Diffuse | - | + | - | Hypoactive | Leukocytosis | CT scan and abdominal X ray | Nausea & vomiting associated with constipation, abdominal distention | ||
Biliary colic | - | RUQ | + | - | - | N | Increased bilirubin and alkaline phosphatase | Ultrasound | Nausea & vomiting | ||
Renal colic | - | Flank pain | - | - | - | N | Hematuria | CT scan and ultrasound | Colicky abdominal pain associated with nausea & vomiting | ||
Vascular Disorders | Ischemic causes | Mesenteric ischemia | +/- | Periumbilical | - | - | - | Hyperactive | Leukocytosis and lactic acidosis | CT scan | Nausea & vomiting, normal physical examination |
Acute ischemic colitis | +/- | Diffuse | - | + | + | Hyperactive then absent | Leukocytosis | CT scan | Nausea & vomiting | ||
Hemorrhagic causes | Ruptured abdominal aortic aneurysm | - | Diffuse | - | - | - | N | Normal | CT scan | Unstable hemodynamics | |
Intra-abdominal or retroperitoneal hemorrhage | - | Diffuse | - | - | - | N | Anemia | CT scan | History of trauma | ||
Gynaecological Causes | Ovarian Cyst Complications | Torsion of the cyst | - | RLQ / LLQ | - | +/- | +/- | N | Increased ESR and CRP | Ultrasound | Sudden onset sever pain with nausea and vomiting |
Cyst rupture | - | RLQ / LLQ | - | +/- | +/- | N | Increased ESR and CRP | Ultrasound | Sudden onset sever pain with nausea and vomiting | ||
Pregnancy | Ruptured ectopic pregnancy | - | RLQ / LLQ | - | - | - | N | Positive pregnancy test | Ultrasound | History of missed period and vaginal bleeding |
References
- ↑ Ejilemele AA, Nwauche CA, Ejele OA (December 2007). "Pattern of abnormal liver enzymes in HIV patients presenting at a Nigerian Tertiary Hospital". Niger Postgrad Med J. 14 (4): 306–9. PMID 18163139.
- ↑ Gøransson LG, Omdal R, Husby G (March 1992). "[Adult-onset Still's disease. Diagnosis, differential diagnosis and treatment]". Tidsskr. Nor. Laegeforen. (in Norwegian). 112 (9): 1155–5. PMID 1579936.
- ↑ Hatakka A, Klein J, He R, Piper J, Tam E, Walkty A (September 2011). "Acute hepatitis as a manifestation of parvovirus B19 infection". J. Clin. Microbiol. 49 (9): 3422–4. doi:10.1128/JCM.00575-11. PMC 3165617. PMID 21734024.
- ↑ Yaguchi D, Marui N, Matsuo M (2015). "Three Adult Cases of HPV-B19 Infection with Concomitant Leukopenia and Low Platelet Counts". Clin Med Insights Case Rep. 8: 19–22. doi:10.4137/CCRep.S18085. PMC 4345940. PMID 25780346.
- ↑ Díaz F, Collazos J (March 2000). "Hepatic dysfunction due to parvovirus B19 infection". J. Infect. Chemother. 6 (1): 63–4. doi:10.1007/s101560000023. PMID 11810534.
- ↑ "watermark.silverchair.com" (PDF).
- ↑ Shetty RK, Vivek G, Naha K, Bekkam S (January 2013). "Right-sided infective endocarditis presenting with purpuric skin rash and cardiac failure in a patient without fever". BMJ Case Rep. 2013. doi:10.1136/bcr-2012-007841. PMC 3603787. PMID 23355575.
- ↑ Aucott JN, Crowder LA, Yedlin V, Kortte KB (2012). "Bull's-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans". Dermatol Res Pract. 2012: 451727. doi:10.1155/2012/451727. PMC 3485866. PMID 23133445.
- ↑ Karaali Z, Baysal B, Poturoglu S, Kendir M (May 2011). "Cutaneous manifestations in brucellosis". Indian J Dermatol. 56 (3): 339–40. doi:10.4103/0019-5154.82505. PMC 3132922. PMID 21772606.
- ↑ La Spada E, Micalizzi A, La Spada M, Quartarano P, Nugara G, Soresi M, Affronti M, Montalto G (September 2008). "[Abnormal liver function in brucellosis]". Infez Med (in Italian). 16 (3): 148–53. PMID 18843212.
- ↑ French P (January 2007). "Syphilis". BMJ. 334 (7585): 143–7. doi:10.1136/bmj.39085.518148.BE. PMC 1779891. PMID 17235095.
- ↑ "Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features".
- ↑ Baveja S, Garg S, Rajdeo A (March 2014). "Syphilitic hepatitis: an uncommon manifestation of a common disease". Indian J Dermatol. 59 (2): 209. doi:10.4103/0019-5154.127711. PMC 3969699. PMID 24700957.
- ↑ Mawhorter SD, Effron D, Blinkhorn R, Spagnuolo PJ (May 1992). "Cutaneous manifestations of toxoplasmosis". Clin. Infect. Dis. 14 (5): 1084–8. PMID 1600010.
- ↑ Flegr J, Prandota J, Sovičková M, Israili ZH (2014). "Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries". PLoS ONE. 9 (3): e90203. doi:10.1371/journal.pone.0090203. PMC 3963851. PMID 24662942.
- ↑ Furtado JM, Smith JR, Belfort R, Gattey D, Winthrop KL (July 2011). "Toxoplasmosis: a global threat". J Glob Infect Dis. 3 (3): 281–4. doi:10.4103/0974-777X.83536. PMC 3162817. PMID 21887062.
- ↑ Ripert C (March 2000). "[Reactive hypereosinophilia in parasitic diseases]". Rev Prat (in French). 50 (6): 602–7. PMID 10808314.
- ↑ Alvarado-Esquivel C, Torres-Berumen JL, Estrada-Martínez S, Liesenfeld O, Mercado-Suarez MF (May 2011). "Toxoplasma gondii infection and liver disease: a case-control study in a northern Mexican population". Parasit Vectors. 4: 75. doi:10.1186/1756-3305-4-75. PMC 3105944. PMID 21569516.
- ↑ Han T, Stutzman L (July 1967). "Mode of spread in patients with localized malignant lymphoma". Arch. Intern. Med. 120 (1): 1–7. PMID 5339237.
- ↑ Saeed-Abdul-Rahman I, Al-Amri AM (September 2012). "Castleman disease". Korean J Hematol. 47 (3): 163–77. doi:10.5045/kjh.2012.47.3.163. PMC 3464333. PMID 23071471.
- ↑ Saeed-Abdul-Rahman I, Al-Amri AM (September 2012). "Castleman disease". Korean J Hematol. 47 (3): 163–77. doi:10.5045/kjh.2012.47.3.163. PMC 3464333. PMID 23071471.
- ↑ Papadavid E, Panayiotides I, Dalamaga M, Katoulis A, Economopoulos T, Stavrianeas N (2010). "Cutaneous involvement in angioimmunoblastic T-cell lymphoma". Indian J Dermatol. 55 (3): 279–80. doi:10.4103/0019-5154.70704. PMC 2965920. PMID 21063526.
- ↑ Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF (2015). "Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM)". Allergo J Int. 24 (3): 94–105. doi:10.1007/s40629-015-0052-6. PMC 4479479. PMID 26120552.
- ↑ Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A (2004). "[Familial Mediterranean Fever (FMF): from diagnosis to treatment]". Sante (in French). 14 (4): 261–6. PMID 15745878.
- ↑ Zhang S (May 2016). "Natural history of mevalonate kinase deficiency: a literature review". Pediatr Rheumatol Online J. 14 (1): 30. doi:10.1186/s12969-016-0091-7. PMC 4855321. PMID 27142780.
- ↑ M. Medlej-Hashim, I. Petit, S. Adib, E. Chouery, N. Salem, V. Delague, M. Rawashdeh, I. Mansour, G. Lefranc, R. Naman, J. Loiselet, J. C. Lecron, J. L. Serre & A. Megarbane (2001). "Familial Mediterranean Fever: association of elevated IgD plasma levels with specific MEFV mutations". European journal of human genetics : EJHG. 9 (11): 849–854. doi:10.1038/sj.ejhg.5200725. PMID 11781702. Unknown parameter
|month=
ignored (help) - ↑ 27.0 27.1 27.2 27.3 Kastner, D. L. (2005). "Hereditary Periodic Fever Syndromes". Hematology. 2005 (1): 74–81. doi:10.1182/asheducation-2005.1.74. ISSN 1520-4391.
- ↑ Kraus, Courtney L; Culican, Susan M (2009). "Nummular keratopathy in a patient with Hyper-IgD Syndrome". Pediatric Rheumatology. 7 (1). doi:10.1186/1546-0096-7-14. ISSN 1546-0096.
- ↑ Mulders-Manders, C. M.; Simon, A. (2015). "Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?". Seminars in Immunopathology. 37 (4): 371–376. doi:10.1007/s00281-015-0492-6. ISSN 1863-2297.
- ↑ Toro, Jorge R.; Aksentijevich, Ivona; Hull, Keith; Dean, Jane; Kastner, Daniel L. (2000). "Tumor Necrosis Factor Receptor–Associated Periodic Syndrome". Archives of Dermatology. 136 (12). doi:10.1001/archderm.136.12.1487. ISSN 0003-987X.
- ↑ Lachmann, H J; Papa, R; Gerhold, K; Obici, L; Touitou, I; Cantarini, L; Frenkel, J; Anton, J; Kone-Paut, I; Cattalini, M; Bader-Meunier, B; Insalaco, A; Hentgen, V; Merino, R; Modesto, C; Toplak, N; Berendes, R; Ozen, S; Cimaz, R; Jansson, A; Brogan, P A; Hawkins, P N; Ruperto, N; Martini, A; Woo, P; Gattorno, M (2014). "The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry". Annals of the Rheumatic Diseases. 73 (12): 2160–2167. doi:10.1136/annrheumdis-2013-204184. ISSN 0003-4967.
- ↑ Hawkins, Philip N.; Lachmann, Helen J.; Aganna, Ebun; McDermott, Michael F. (2004). "Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra". Arthritis & Rheumatism. 50 (2): 607–612. doi:10.1002/art.20033. ISSN 0004-3591.
- ↑ Ahmadi, Neda; Brewer, Carmen C.; Zalewski, Christopher; King, Kelly A.; Butman, John A.; Plass, Nicole; Henderson, Cailin; Goldbach-Mansky, Raphaela; Kim, H. Jeffrey (2011). "Cryopyrin-Associated Periodic Syndromes". Otolaryngology–Head and Neck Surgery. 145 (2): 295–302. doi:10.1177/0194599811402296. ISSN 0194-5998.
- ↑ Stych, Beate; Dobrovolny, Diana (2008). "Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives". Current Medical Research and Opinion. 24 (6): 1577–1582. doi:10.1185/03007990802081543. ISSN 0300-7995.
- ↑ Goldbach-Mansky, Raphaela; Dailey, Natalie J.; Canna, Scott W.; Gelabert, Ana; Jones, Janet; Rubin, Benjamin I.; Kim, H. Jeffrey; Brewer, Carmen; Zalewski, Christopher; Wiggs, Edythe; Hill, Suvimol; Turner, Maria L.; Karp, Barbara I.; Aksentijevich, Ivona; Pucino, Frank; Penzak, Scott R.; Haverkamp, Margje H.; Stein, Leonard; Adams, Barbara S.; Moore, Terry L.; Fuhlbrigge, Robert C.; Shaham, Bracha; Jarvis, James N.; O'Neil, Kathleen; Vehe, Richard K.; Beitz, Laurie O.; Gardner, Gregory; Hannan, William P.; Warren, Robert W.; Horn, William; Cole, Joe L.; Paul, Scott M.; Hawkins, Philip N.; Pham, Tuyet Hang; Snyder, Christopher; Wesley, Robert A.; Hoffmann, Steven C.; Holland, Steven M.; Butman, John A.; Kastner, Daniel L. (2006). "Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition". New England Journal of Medicine. 355 (6): 581–592. doi:10.1056/NEJMoa055137. ISSN 0028-4793.
- ↑ Kim, Hanna; Montealegre Sanchez, Gina A.; Chapelle, Dawn C.; Plass, Nicole; Dwyer, Andrew; Goldbach-Mansky, Raphaela; Hill, Suvimol (2014). "A80: Skeletal Features of Neonatal-Onset Multisystem Inflammatory Disease (NOMID) on Anakinra Treatment: Long-Term Follow-up". Arthritis & Rheumatology. 66: S113–S113. doi:10.1002/art.38496. ISSN 2326-5191.
- ↑ Yeon, Howard B.; Lindor, Noralane M.; Seidman, J.G.; Seidman, Christine E. (2000). "Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome Maps to Chromosome 15q". The American Journal of Human Genetics. 66 (4): 1443–1448. doi:10.1086/302866. ISSN 0002-9297.
- ↑ Schellevis, M. A.; Stoffels, M.; Hoppenreijs, E. P. A. H.; Bodar, E.; Simon, A.; van der Meer, J. W. M. (2011). "Variable expression and treatment of PAPA syndrome". Annals of the Rheumatic Diseases. 70 (6): 1168–1170. doi:10.1136/ard.2009.126185. ISSN 0003-4967.
- ↑ Vanoni, Federica; Federici, Silvia; Antón, Jordi; Barron, Karyl S.; Brogan, Paul; De Benedetti, Fabrizio; Dedeoglu, Fatma; Demirkaya, Erkan; Hentgen, Veronique; Kallinich, Tilmann; Laxer, Ronald; Russo, Ricardo; Toplak, Natasa; Uziel, Yosef; Martini, Alberto; Ruperto, Nicolino; Gattorno, Marco; Hofer, Michael (2018). "An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA)". Pediatric Rheumatology. 16 (1). doi:10.1186/s12969-018-0246-9. ISSN 1546-0096.
- ↑ Cattalini, Marco; Soliani, Martina; Rigante, Donato; Lopalco, Giuseppe; Iannone, Florenzo; Galeazzi, Mauro; Cantarini, Luca (2015). "Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease". Mediators of Inflammation. 2015: 1–11. doi:10.1155/2015/570418. ISSN 0962-9351.
- ↑ Gattorno, M.; Caorsi, R.; Meini, A.; Cattalini, M.; Federici, S.; Zulian, F.; Cortis, E.; Calcagno, G.; Tommasini, A.; Consolini, R.; Simonini, G.; Pelagatti, M. A.; Baldi, M.; Ceccherini, I.; Plebani, A.; Frenkel, J.; Sormani, M. P.; Martini, A. (2009). "Differentiating PFAPA Syndrome From Monogenic Periodic Fevers". PEDIATRICS. 124 (4): e721–e728. doi:10.1542/peds.2009-0088. ISSN 0031-4005.
- ↑ Rosé, Carlos D.; Aróstegui, Juan I.; Martin, Tammy M.; Espada, Graciela; Scalzi, Lisabeth; Yagüe, Jordi; Rosenbaum, James T.; Modesto, Consuelo; Cristina Arnal, Maria; Merino, Rosa; García-Consuegra, Julia; Carballo Silva, María Antonia; Wouters, Carine H. (2009). "NOD2-Associated pediatric granulomatous arthritis, an expanding phenotype: Study of an international registry and a national cohort in spain". Arthritis & Rheumatism. 60 (6): 1797–1803. doi:10.1002/art.24533. ISSN 0004-3591.
- ↑ Kim, Woojoong; Park, Eujin; Ahn, Yo Han; Lee, Jiwon M.; Kang, Hee Gyung; Kim, Byung Joo; Ha, Il-Soo; Cheong, Hae Il (2016). "A familial case of Blau syndrome caused by a novelNOD2genetic mutation". Korean Journal of Pediatrics. 59 (Suppl 1): S5. doi:10.3345/kjp.2016.59.11.S5. ISSN 1738-1061.